Abdominal Aortic Aneurysm (AAA) Repair Devices Market Growth, Size, Share, Trends, Key Players Analysis, and Forecast till 2034

The abdominal aortic aneurysm repair devices market size is projected to grow from US$ 2.26 Billion in 2025 to US$ 3.89 Billion by 2034; it is expected to register a CAGR of 6.2% during 2026–2034. Demand is supported by expanding endovascular aneurysm repair adoption, wider screening of high-risk older adults, and continuing device innovation in low-profile, conformable, fenestrated, and branched graft designs.

North America remains the most structurally mature region, supported by vascular surgery capacity, established reimbursement, FDA-regulated product pathways, and clinical preference for minimally invasive repair in eligible anatomy. The region is expected to expand at a CAGR of 5.7–6.3% during 2026–2034, driven by aging populations, persistent smoking-related vascular disease burden, and hospital investments in hybrid operating rooms.

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Assessment and Insights

The changing design is moving the AAA repair devices market away from open surgery replacement to anatomy-specific endovascular planning. Low profile deployment systems, increased sealing area, active fixation, and fenestrations are increasing the patient eligibility pool. Production is becoming increasingly specialized as manufacturers attempt to find the right balance between pre-manufactured grafts and patient-specific planning, regulation requirements, sterilization process, imaging, and physician training considerations in vascular centers.

Future demand will depend on new vascular program launches in Asia Pacific, selective growth in the Middle East, and registry-based adoption in complex anatomy repair. Regulations favor products that have a track record of long term surveillance, registry results, and safety information after market entry. The most favorable conditions for market growth in the abdominal aortic aneurysm repair devices market include early disease diagnosis, hybrid operating rooms, vascular specialists, and appropriate reimbursement for endovascular treatment.

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Report Scope

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Analysis

The demand is mainly driven by diagnosed aneurysms needing elective repair, emergency repair of ruptured aneurysms, and transition from surveillance to surgical repair of an aneurysm due to surveillance results. The analysis of the abdominal aortic aneurysm repair devices market reveals that ultrasound screening, CT angiography, vascular pathway referral, and perioperative risk assessment impact the procedure volume. EVAR stays the preferred technique for anatomically eligible patients due to lower surgical trauma and faster recovery as opposed to open surgery.

The market environment consists of graft producers, manufacturers of materials like nitinol and polyester, imaging technologies vendors, catheterization labs, hybrid ORs, vascular surgeons, interventional radiologists, and payers. The supply is impacted by sterilization capacity, sizes of device inventory, training, and long-term follow-up regulations. The hospitals tend to choose vendors providing not only diverse range of grafts but also support in planning and documentation.

Competition is concentrated among companies with established aortic franchises and differentiated device platforms. Medtronic plc and W. L. Gore & Associates, Inc. compete through broad EVAR portfolios and clinical evidence, while Cook Medical LLC and Terumo Corporation emphasize fenestrated and complex anatomy capabilities. Endologix LLC focuses on differentiated sealing and fixation concepts, and Artivion, Inc. strengthens its aortic position through acquired endovascular technologies.

Investment activity is directed toward lower-profile systems, complex aneurysm repair, urgent-use platforms, and bridging stents for fenestrated procedures. The abdominal aortic aneurysm repair devices market trends show that strategic positioning depends less on single-device launches and more on full procedural ecosystems. Companies with training infrastructure, registry participation, physician education, and regulatory adaptability are better positioned to protect abdominal aortic aneurysm repair devices market share.

Abdominal Aortic Aneurysm (AAA) Repair Devices Market: Strategic Insights

Regional Insights

North America Abdominal Aortic Aneurysm Repair Devices Market

North America accounts for 38–42% share in 2025 and is projected to grow at a CAGR of 5.7–6.3% during 2026–2034. Demand is supported by advanced vascular surgery networks, routine imaging use, risk-based screening of older adults, and established hospital reimbursement for endovascular repair. The region also benefits from strong post-market surveillance infrastructure and early adoption of approved graft refinements. Hospitals increasingly use EVAR for infrarenal aneurysms and selectively adopt fenestrated or branched approaches for complex anatomy. The abdominal aortic aneurysm repair devices market scope in North America is expanding through hybrid operating room investments, physician-led device selection, and growing emphasis on long-term sac behavior, endoleak management, and reintervention reduction.

U.S. Abdominal Aortic Aneurysm Repair Devices Market

The US represents 82–86% of North America in 2025 and is expected to expand at a CAGR of 5.6–6.2% during 2026–2034. Procedure demand is supported by Medicare-aged patient volumes, vascular specialist concentration, FDA-cleared device availability, and hospital preference for minimally invasive aneurysm repair where anatomical criteria are met. Company presence remains strong, with Medtronic plc, W. L. Gore & Associates, Inc., Cook Medical LLC, Endologix LLC, Terumo Corporation, and Cardinal Health, Inc. serving hospitals through graft platforms, surgical supplies, and technical support. Application trends are moving toward complex EVAR planning, rupture labeling evidence, and structured imaging follow-up after implantation.

Europe abdominal aortic aneurysm repair devices market

Europe holds 27–31% share in 2025 and is projected to grow at a CAGR of 5.2–5.8% during 2026–2034. The UK benefits from organized vascular services, screening programs for older men, and centralized aneurysm repair pathways that support consistent referral and EVAR suitability evaluation. The Germany market is dominant among other markets within Europe due to its capability in hospital procedures, the existence of specialty vascular centers, and use of sophisticated endovascular technology platforms. Procurements will continue to be impacted by long-term durability data, conformability, endoleaks, and complex solutions to treat juxtarenal and short-neck aneurysms. Other key markets that drive demand in Europe include France, Italy, and Spain via their government hospitals, privately owned vascular units, and minimal invasive repair procedures. Adoption rates will depend on reimbursement, availability of training, and experience of the institution in terms of fenestration planning.

APAC abdominal aortic aneurysm repair devices market

Asia Pacific accounts for 20–24% share in 2025 and the abdominal aortic aneurysm repair devices market forecast is to grow at a CAGR of 7.1–7.8% during 2026–2034. China leads regional demand through hospital infrastructure expansion, domestic device growth, and rising access to vascular imaging. Japan and South Korea show mature adoption supported by specialist centers and advanced imaging. Australia maintains high clinical standards and selective use of complex endovascular repair. India is scaling from a smaller base as tertiary hospitals add vascular programs. Policy support for medical technology localization, broader insurance coverage, and private hospital investment reinforce the region’s long-term role in abdominal aortic aneurysm repair devices market size expansion.

Middle East & Africa abdominal aortic aneurysm repair devices market

The Middle East & Africa abdominal aortic aneurysm repair devices market is projected to grow at a CAGR of 4.8–5.4% during 2026–2034. Saudi Arabia leads adoption as tertiary hospitals expand cardiovascular and vascular surgery capabilities under healthcare infrastructure programs. The UAE supports demand through medical tourism, private hospitals, and access to imported advanced devices. Complex EVAR uptake remains concentrated in high-acuity specialist centers. South Africa anchors demand in Sub-Saharan Africa, while the Rest of MEA remains limited by specialist availability and reimbursement gaps. Energy-linked public investment and hospital modernization support selective growth, particularly for premium endovascular platforms.

Segmentation Analysis

Type

The Type segment in the abdominal aortic aneurysm repair devices market is expected to grow at a CAGR of 6.1–6.6% during 2026–2034. Demand is led by endovascular systems because eligible patients and physicians prefer less invasive treatment, shorter hospitalization, and reduced perioperative burden. Synthetic graft systems remain important for open repair, unsuitable anatomy, infection-related cases, and younger patients where long-term surgical durability is prioritized.

• Endovascular Stent Graft System dominates current demand, supported by infrarenal AAA repair, expanding device configurations, improved delivery profiles, and physician preference for minimally invasive procedures in high-risk surgical candidates.
• Synthetic Graft System retains strategic importance in open surgical repair, anatomically unsuitable EVAR cases, infected graft management, and complex revision procedures requiring durable vascular reconstruction.

Anatomy

The Anatomy segment in the abdominal aortic aneurysm repair devices market is expected to grow at a CAGR of 6.3–6.9% during 2026–2034. Traditional anatomy remains the procedural foundation because standard infrarenal neck criteria support predictable EVAR outcomes. Complex anatomy is gaining importance as fenestrated, branched, and physician-modified strategies improve options for short-neck, angulated, juxtarenal, and pararenal aneurysms.

• Traditional Anatomy represents the main procedural base, where standard EVAR devices offer predictable sealing, established physician familiarity, inventory efficiency, and faster treatment workflows in elective aneurysm cases.
• Complex Anatomy is strategically important as manufacturers develop fenestrated, branched, and conformable systems that address difficult neck morphology and expand minimally invasive treatment eligibility.

Site

The Site segment in thw abdominal aortic aneurysm repair devices market is expected to grow at a CAGR of 5.9–6.5% during 2026–2034. Infrarenal AAA remains the principal site because it represents the largest treatable pool for standard EVAR. Pararenal AAA requires advanced planning and specialized devices, making it smaller but strategically important for premium pricing, specialist differentiation, and long-term innovation.

• Infrarenal AAA drives the highest procedural volume, supported by standard EVAR suitability, wider graft availability, established guidelines, and repeatable hospital workflows for elective aneurysm exclusion.
• Paraneal AAA requires advanced endovascular planning, fenestration alignment, renal vessel preservation, and specialist expertise, making it a key target for premium complex repair technologies.

Opportunity Snapshot

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Growth Drivers and Impact Analysis

Rising Preference for Endovascular Aneurysm Repair

The increasing utilization of EVAR represents the most influential factor within the abdominal aortic aneurysm repair device market since it corresponds to hospital strategy concerning minimization of length of stay, low surgical invasiveness, and fast recovery in eligible patients. Such trend is especially relevant in the case of older patients with the presence of co-morbidities of the cardiovascular system, who cannot tolerate surgical intervention. Device manufacturers have been developing more discrete delivery systems, improved fixation, and better proximal sealing due to irregular vessel anatomy, which makes possible treatment of a broader group of patients rather than infrarenal ones only.

Expanding Screening and Imaging-Based Diagnosis

The diagnosis is advancing through ultrasound scanning, CT angiography, incidental scans, and risk assessment for vascular disease to detect aneurysms prior to rupture. Screening criteria for older men who have smoked provide a reliable source of referrals, and wider abdominal imaging can detect aneurysms when not directly scanning for one. Early diagnosis enables elective surgery that is much more reliable and predictable, allowing device sizing and physician preparation. The effect on the market will be increased uptake of surveillance aneurysms for planned EVAR or surgical aneurysm repair.

Growing Capability to Treat Complex Anatomy

Complex anatomy is becoming commercially important because a large share of patients do not fit ideal infrarenal EVAR criteria. Short necks, severe angulation, thrombus, calcification, renal artery involvement, and pararenal extension create treatment limitations. Fenestrated, branched, conformable, and physician-modified approaches are gradually addressing these gaps. Manufacturers with planning support and clinical evidence can capture higher-value procedures in specialist centers. The market impact is a shift toward premium devices, longer physician training cycles, and stronger collaboration between manufacturers, imaging teams, and vascular surgeons during patient-specific procedural planning.

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Future Trends

Integration of Device Planning with Advanced Imaging

The abdominal aortic aneurysm repair devices market trends will increasingly depend on software-assisted measurements, three-dimensional reconstruction, and standardized reporting of neck length, angulation, branch vessel position, thrombus, calcification, and iliac access. This trend will reduce sizing errors and improve consistency among hospitals performing complex EVAR. Manufacturers are expected to bundle planning support with graft systems, particularly for fenestrated and branched repair. Over time, imaging-linked workflows may also strengthen post-procedure surveillance by tracking sac regression, migration, and endoleak patterns. This trend supports value-based procurement by connecting device choice with measurable clinical performance.

Shift Toward Evidence-Backed Complex EVAR Platforms

The next phase of innovation will focus on complex aneurysm repair supported by prospective studies, post-market registries, and real-world follow-up rather than technical novelty alone. Regulators and hospitals increasingly require evidence on target vessel patency, reintervention, rupture prevention, sac behavior, and long-term durability. Companies that generate structured evidence for juxtarenal, pararenal, and urgent complex aneurysm cases will gain stronger specialist confidence. This trend may also narrow product selection in advanced centers as clinical teams standardize around platforms with proven planning systems, training support, and predictable outcomes.

Abdominal Aortic Aneurysm (AAA) Repair Devices Market Opportunities

Expansion in High-Growth Asian Vascular Centers

Asia Pacific offers a clear investment opportunity as tertiary hospitals in China, India, South Korea, and Southeast Asia expand vascular surgery and interventional radiology capabilities. Companies can strengthen uptake by combining device availability with physician training, case planning, local regulatory engagement, and distributor support. The opportunity is strongest for low-profile EVAR systems suited to smaller vessel access and complex anatomy platforms that differentiate premium centers. Localized education and evidence generation will be essential because adoption depends on physician confidence, reimbursement coverage, and hospital ability to manage long-term follow-up.

Premium Solutions for Pararenal and Juxtarenal Disease

Pararenal and juxtarenal aneurysms remain underpenetrated by standard EVAR, creating room for differentiated devices and service models. Manufacturers can target specialist centers with fenestrated grafts, branched systems, bridging stents, rapid planning support, and technical proctoring. This opportunity is commercially attractive because complex cases carry higher clinical value, stronger physician engagement, and greater need for customized device ecosystems. Success will depend on reducing manufacturing lead times, improving anatomical fit, documenting renal vessel outcomes, and enabling hospitals to treat urgent cases without excessive procedural delay.

Recent Developments

• November 2025: Terumo Corporation announced enrollment of the first patient in the Fenestrated TREO pivotal IDE study in the US, designed to evaluate endovascular repair of juxtarenal and suprarenal aortic aneurysms using the Fenestrated TREO Abdominal Stent-Graft System across up to 45 US sites.
• October 2025: Medtronic received US FDA labeling approval for the Endurant stent graft system, adding clinical evidence for ruptured abdominal aortic aneurysm treatment and removing the ruptured AAA treatment warning from the device instructions for use, strengthening its evidence position in emergency EVAR applications.
• August 2025: Cook Medical enrolled the final patient in the global clinical study of its investigational ZENITH FENESTRATED+ Endovascular Graft, a pivotal study evaluating a patient-specific fenestrated solution for complex abdominal and thoracoabdominal aneurysms under FDA IDE and UK MHRA authorization.